Clinical Edge Journal Scan

Increasing Dietary Vitamin C Intake May Prevent Severe Headache or Migraine


 

Key clinical point: Dietary vitamin C intake was negatively associated with the risk for severe headache or migraine.

Major finding: Each 1 mg/day increase in dietary vitamin C intake was significantly associated with a 6% lower risk for severe headache or migraine (adjusted odd ratio [aOR] 0.94; P = .0007). This inverse association between dietary vitamin C intake and severe headache or migraine risk was significant in women (aOR 0.90; 95% CI 0.87-0.85) but not in men.

Study details: This cross-sectional study included 13,445 participants from the National Health and Nutrition Examination Survey, of whom 2745 (20.42%) had severe headache or migraine.

Disclosures: This study did not receive any specific funding. The authors declared no conflicts of interest.

Source: Zheng Y, Jin J, Wei C, Huang C. Association of dietary vitamin C consumption with severe headache or migraine among adults: A cross-sectional study of NHANES 1999–2004. Front Nutr. 2024;11 :fnut.2024.1412031 (Jun 18). Doi: 10.3389/fnut.2024.1412031 Source

Recommended Reading

Eptinezumab Inhibitor Fails Cluster Headache Test
Migraine ICYMI
Neck Pain in Migraine Is Common, Linked to More Disability
Migraine ICYMI
Atogepant Effective in Chronic Migraine, Irrespective of Acute Medication Overuse
Migraine ICYMI
Patients With Migraine Have Higher Risk for Retinal Vascular Occlusion
Migraine ICYMI
Erenumab Treatment Interruption May Worsen Episodic or Chronic Migraine Symptoms
Migraine ICYMI
Patients with CGRP-Induced Migraine Attacks Can Benefit With Erenumab
Migraine ICYMI
Long-term Eptinezumab Benefits Patients With Chronic Migraine and Medication-Overuse Headache
Migraine ICYMI
Does Migraine Influence Serum Alpha-CGRP Levels in Patients With IBD?
Migraine ICYMI
Neck Pain With Headache During Migraine Tied to Poor Migraine Health
Migraine ICYMI
Sustained Benefits of CGRP Antibodies in Migraine and Medication Overuse Headache
Migraine ICYMI